Tumor-associated antigen presented by major histocompatibility complex class I on dendritic cell

Tumor-associated antigens presented by major histocompatibility complex class I molecules on dendritic cells refer to short peptide fragments derived from proteins that are abnormally expressed or mutated in cancer cells. These peptides are processed and loaded onto MHC class I molecules within dendritic cells, which then display them at the cell surface. This process is critical for activating cytotoxic CD8+ T lymphocytes, which can recognize and kill cancerous or infected target cells displaying these same antigenic peptides. Dendritic cells are uniquely efficient at presenting exogenous proteins through a process called cross-presentation, allowing them to prime naive CD8+ T-cell responses against tumors even when those tumors do not directly infect immune tissues. This mechanism forms the basis for several immunotherapeutic strategies—including peptide vaccines and adoptive cellular therapies—aiming to boost anti-tumor immunity. However, challenges include heterogeneity in antigen expression among tumors and immune evasion mechanisms such as downregulation or loss of MHC class I expression by cancer cells themselves[1][2]. The term as written is not a single molecular entity but rather describes a functional immune complex; thus it is not a canonical "target" like an enzyme or receptor protein but represents an important therapeutic axis in oncology immunotherapy. The entry is considered "incorrect" as a canonical drug target because it refers broadly to any tumor-derived peptide-MHC-I combination presented by any dendritic cell rather than specifying one molecular species; however, it remains highly relevant as an immunotherapy focus area[2].

Other names

Tumor antigen-MHC I complex on dendritic cellMHC class I-presented tumor antigens on dendritic cellDC-presented tumor-associated antigens (MHC I)

Induction of anti-tumor CD8+ T-cell responses via recognition of tumor-derived peptides bound to MHC class I molecules on the surface of dendritic cells[1][2]